Peripheral/Endo

Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements

OXFORDSHIRE, U.K. & SHANGHAI–(BUSINESS WIRE)– Lombard Medical, Inc. (EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (0853.HK), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced the parties have finalized the definitive agreements to their strategic partnership first […]

First U.S. Patient Treated in Landmark Vascular Study of Lithoplasty® Technology

NEWS PROVIDED BY PinnacleHealth System | 05 Apr, 2017, 10:00 ET HARRISBURG, Pa., April 5, 2017 /PRNewswire/ — PinnacleHealth CardioVascular Institute enrolled the first patient in the United States in a trial assessing the safety and effectiveness of a new type of approach for blockages in the leg artery. DISRUPT PAD III is […]

Ra Medical Systems Launches Cardiovascular and Dermatology Catheters and Lasers in Northern Europe

Carlsbad, CA—April 6, 2017 (BUSINESS WIRE) Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases, and bo medical technologies, a multinational medical device sales and service distributor, announce the launch of the DABRA Atherectomy System for cardiovascular and Pharos Excimer Laser for dermatology in Europe. […]

Cordis, a Cardinal Health Company, introduces innovative products at EUROPCR 2017 to rapidly expand interventional cardiology offering

PCRonline/News/Industry Press Releases – 15 May, 2017 DUBLIN, Ohio. Cordis, Cardinal Health‘s interventional vascular business, announced today the commercial launch of three new products that further enhance its interventional cardiology product portfolio in Europe, the Middle East, and Africa (EMEA). The addition of the Cordis RAILWAY Sheathless Access System as well […]

SoCal’s Endologix Gets $170 Million Injection to Advance Aortic Disorder Treatment

Endologix Enters into $170 Million Credit Facility with Deerfield Management IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it has entered into an agreement with Deerfield Management (“Deerfield”), a leading healthcare investment organization, to provide Endologix with up to $170 […]

Essential Medical, Inc., Addressing the Rapidly Growing Large Bore Vascular Closure Market

MALVERN, Pennsylvania, April 3, 2017 /PRNewswire/ — Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced the publication of the MANTA CE marking study results in JACC Interventions titled: “Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access” (http://dx.doi.org/10.1016/j.jcin.2016.12.277). This first, […]

Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements

April 03, 2017 06:00 AM Eastern Daylight Time OXFORDSHIRE, U.K. & SHANGHAI–(BUSINESS WIRE)–Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced the parties have […]

Endologix announces enrolment of first patients in ELEVATE IDE clinical study

Mar 31, 2017 – IRVINE, Calif.–(BUSINESS WIRE)– Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the first patients were treated in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study, the Company’s pivotal clinical trial to […]

Utah’s Merit Medical (MMSI) Prices $136.5 Million Offering

Merit Medical Announces Closing of Public Offering of Common Stock SOUTH JORDAN, Utah, March 29, 2017 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI) (“Merit”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, today announced that […]

Metactive Medical Announces Issuance of Patents on Blockstent and Ballstent Embolization Devices

OLATHE, Kan.–(BUSINESS WIRE)–Metactive Medical Inc. (Metactive), an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, today announced the issuance of US Patents 9,572,697 and 9,572,698 covering its Ballstent Microcatheter™ for embolization of cerebral aneurysms, and its Blockstent Microcatheter™ for embolization of peripheral […]